US Stock Market Move | Lilly (LLY.US) rose by 3.8%, with major Wall Street firms maintaining their "buy" rating.
As of the press deadline, the stock rose by 3.8% to $649.66.
On Monday, the stock price of Eli Lilly (LLY.US) rose, as of the time of writing, the stock was up 3.8% at $649.66. On the news front, Deutsche Bank Aktiengesellschaft analyst James Shin maintained a "buy" rating on Eli Lilly, but lowered the target price to $900. Analysts from Furry Group, Morgan Stanley, J.P. Morgan, Citigroup, and Truist Financial also maintained a "buy" rating on the stock.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
